Table 1.
Subset 1 (n = 36) | Subset 2 (n = 32) | |||||||
---|---|---|---|---|---|---|---|---|
R (n = 17) | NR (n = 19) | R (n = 19) | NR (n = 13) | |||||
0 months | 6 months | 0 months | 6 months | 0 months | 6 months | 0 months | 6 months | |
Age (years) | 49.94 +/- 3.63 | 57.68 +/- 2.67 | 55.32 +/- 3.02 | 58.46 +/- 3.32 | ||||
Sex (F/M), number | 17/0* | 14/5 | 15/4 | 10/3 | ||||
Disease duration (years) | 3.71 +/- 0.86** | 10.68 +/- 2.65 | 5.42 +/- 1.44** | 12.85 +/- 3.1 | ||||
Methotrexate dose (mg/week) | 15.29 +/- 1.28 | 16.58 +/- 3.99 | 18.03 +/- 3.85 | 15.58 +/- 3.42 | ||||
Corticosteroid dose (mg/day) | 2.44 +/- 0.77 | 2.71 +/- 0.75 | 2.64 +/- 0.8 | 3.46 +/- 1.14 | ||||
Tender joint count/28 | 10.29 +/- 1.48 | 1.47 +/- 0.5$$$ | 14.42 +/- 1.46£££ | 6.37 +/- 0.79 | 11.10 +/- 1.56 | 1.32 +/- 0.37$$$ | 11.46 +/- 2.05 | 6.92 +/- 1.68£££ |
Swollen joint count/28 | 10.24 +/- 1.31 | 2.59 +/- 0.74$$$ | 11.26 +/- 0.92£££ | 6.21 +/- 1.10 | 9.63 +/- 1.15 | 1.74 +/- 0.49$$$ | 10.85 +/- 1.41 | 5.08 +/- 0.81£££ |
Patient assessment of disease (VAS scale/100 mm) | 58.24 +/- 5.91* | 16.29 +/- 4.37$$$ | 68.58 +/- 4.28£££ | 35.68 +/- 4.85 | 48.95 +/- 4.83* | 19.74 +/- 3.87$$$ | 60.62 +/- 5.37 | 37.08 +/- 5.35£££ |
DAS28(CRP) | 4.98 +/- 0.24** | 2.37 +/- 0.13$$$ | 5.90 +/- 0.2£££ | 4.20 +/- 0.19 | 4.86 +/- 0.23** | 2.41 +/- 0.11$$$ | 5.35 +/- 0.25 | 4.13 +/- 0.27£££ |
CRP (mg/L) | 7.24 +/- 1.42** | 2.18 +/- 0.44$$$ | 27.69 +/- 6.71££ | 12.34 +/- 3.46 | 8.16 +/- 2.44** | 3.56 +/- 0.83$$$ | 16.64 +/- 5.39 | 11.38 +/- 2.46££ |